Can you take COVID-19 mRNA (Pfizer) vaccine with Delgocitinib topical?
1 drug interaction found for the following 2 drugs:
- COVID-19 mRNA (Pfizer) vaccine
- delgocitinib topical
Drug interactions
Moderate drug interactions
Moderate:
SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 309) delgocitinib topical
Applies to: COVID-19 mRNA (Pfizer) vaccine and delgocitinib topical
If you are currently being treated or have recently been treated with delgocitinib topical, you should let your doctor know before receiving SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 309). Depending on the dose and length of time you have been on delgocitinib topical, you may have a reduced response to the vaccine. In some situations, your doctor may want to alter vaccination schedule. If you have recently been vaccinated with SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 309), your doctor may choose to postpone treatment with delgocitinib topical for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Food/lifestyle interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Disease interactions
No disease interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
More resources
COVID-19 mRNA (Pfizer) vaccine
A total of 388 drugs are known to interact with COVID-19 mRNA (Pfizer) vaccine.
- Covid-19 mrna (pfizer) vaccine is in the drug class viral vaccines.
- Covid-19 mrna (pfizer) vaccine is used to treat COVID-19 (off-label).
delgocitinib topical
A total of 334 drugs are known to interact with delgocitinib topical.
- Delgocitinib topical is in the drug class miscellaneous topical agents.
- Delgocitinib topical is used to treat Eczema.
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.